KISHORKUMAR DEDANIA: Open Payments
NPI 1912943986 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 53 payments from 7 companies in 2025. Trend: 2023 $657 · 2024 $886 · 2025 $2,131
Food & beverage: $2,019Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $570 |
| E.R. Squibb & Sons, L.L.C. | 8 | $563 |
| Otsuka America Pharmaceutical, Inc. | 7 | $341 |
| Neurocrine BioSciences, Inc. | 9 | $322 |
| Janssen Pharmaceuticals, Inc | 8 | $272 |
| Alkermes, Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $22 |
Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, UZEDY, AUSTEDO XR, ABILIFY MAINTENA, BREYANZI, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
